Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Shaun Hiu

MSc


Medical Statistician

I joined the Primary Care Clinical Trials Unit as a Medical Statistician in November 2024. I am currently involved in the design of a platform trial called the Early Psychosis Multi-arm, Multi-stage Platform Trial (PUMA), which seeks to evaluate multiple potential treatments for people with early psychosis.

Prior to my time at the PC-CTU, I studied Psychology for my Bachelor’s and Master’s and spent some time doing research in areas of ageing such as dementia and workplace ageism during this period. I then joined the Biostatistics Research Group at Newcastle University in 2019. I worked as a trial statistician spanning areas such as head and neck cancer, childhood obesity, frailty, stroke, rheumatoid arthritis, and paediatric nephrology. I also worked on large observational datasets such as the UK Primary Biliary Cholangitis (UK-PBC) cohort, UK Biobank, and the Clinical Practice Research Datalink (CPRD). During my time at Newcastle, I was fortunate to secure an NIHR pre-doctoral fellowship award to gain hands-on experience applying methods and concepts in causal inference towards clinical trials and the emulation of clinical trials with large observational datasets. I am studying part-time for an MS in Statistics with Medical Applications.

My research interests include the application of causal inference methods (such as inverse probability weighting and g-computation) to clinical trials and observational data, Bayesian statistics and inference, and recently trials that use Master Protocols. I am currently collaborating with investigators on the AI-MULTIPLY consortium to plan and design emulations of clinical trials surrounding polypharmacy and multiple long-term conditions using UK primary care data.